{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:43Z","timestamp":1791849403176,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent and intractable hiccups may indicate brainstem pathology rather than benign gastrointestinal causes. Among inflammatory demyelinating disorders, neuromyelitis optica spectrum disorder (NMOSD) frequently involves the dorsal medulla, particularly the area postrema, a key structure in the hiccup reflex arc. Area postrema syndrome (APS), characterized by otherwise unexplained hiccups, nausea, or vomiting lasting\u2009\u2265\u200948\u00a0h, represents a core diagnostic feature of NMOSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A structured narrative literature review was conducted using PubMed, Scopus, and Web of Science databases from inception to January 2026. Studies addressing persistent or intractable hiccups associated with demyelinating disorders, including NMOSD, multiple sclerosis, and myelin oligodendrocyte glycoprotein antibody\u2013associated disease (MOGAD), were analyzed with emphasis on neuroanatomical, immunopathological, and radiological correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NMOSD is the prototypical demyelinating disorder associated with intractable hiccups due to selective astrocytic injury in the area postrema. APS may precede optic neuritis or myelitis and can represent the initial manifestation of disease. Multiple sclerosis and MOGAD may also involve the brainstem but differ in lesion distribution, immunopathology, and treatment implications. Early recognition of dorsal medullary involvement and antibody testing is critical for accurate diagnosis and timely immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intractable hiccups should be recognized as a potential brainstem red flag symptom. Awareness of their association with NMOSD and related demyelinating disorders facilitates early diagnosis, appropriate immunotherapy, and prevention of neurological disability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09288-7","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:50:50Z","timestamp":1786776650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-0039","authenticated-orcid":false,"given":"Sinan","family":"Elia\u00e7\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"5","key":"9288_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0196-0644(05)81620-8","volume":"20","author":"PW Kolodzik","year":"1991","unstructured":"Kolodzik PW, Eilers MA (1991) Hiccups (singultus): review and approach to management. Ann Emerg Med 20(5):565\u2013573","journal-title":"Ann Emerg Med"},{"key":"9288_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/apt.13374","volume":"42","author":"M Steger","year":"2015","unstructured":"Steger M, Schneemann M, Fox M (2015) Systematic review: the pathogenesis and pharmacological treatment of hiccups. Aliment Pharmacol Ther 42:1037\u20131050","journal-title":"Aliment Pharmacol Ther"},{"key":"9288_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"9288_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1212\/WNL.0b013e31824f8069","volume":"78","author":"SH Kim","year":"2012","unstructured":"Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ (2012) Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology 78:1179\u20131185","journal-title":"Neurology"},{"issue":"7","key":"9288_CR5","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","volume":"270","author":"S Jarius","year":"2023","unstructured":"Jarius S, Ruprecht K, Ayzenberg I et al (2023) Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u2013revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol 270(7):3341\u20133368","journal-title":"J Neurol"},{"issue":"2","key":"9288_CR6","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000011153","volume":"96","author":"V Papp","year":"2021","unstructured":"Papp V, Magyari M, Aktas O et al (2021) Incidence and prevalence of NMOSD: a systematic review. Neurology 96(2):e59\u2013e77","journal-title":"Neurology"},{"key":"9288_CR7","first-page":"2798","volume":"100","author":"Y Oshima","year":"2008","unstructured":"Oshima Y, Sakamoto M, Tsuboi Y, Hayashi A, Hirano T, Itoh K (2008) Brainstem control of hiccup reflex. J Neurophysiol 100:2798\u20132806","journal-title":"J Neurophysiol"},{"key":"9288_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"9288_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF et al (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin-4 expression. Arch Neurol 63:964\u2013968","journal-title":"Arch Neurol"},{"key":"9288_CR10","first-page":"1645","volume":"74","author":"M Apiwattanakul","year":"2010","unstructured":"Apiwattanakul M, Popescu BF, Matiello M et al (2010) Intractable vomiting as the initial presentation of neuromyelitis optica. Neurology 74:1645\u20131652","journal-title":"Neurology"},{"key":"9288_CR11","first-page":"2969","volume":"133","author":"BF Popescu","year":"2010","unstructured":"Popescu BF, Lennon VA, Parisi JE et al (2010) Neuromyelitis optica pathology: astrocytic loss and complement deposition. Brain 133:2969\u20132982","journal-title":"Brain"},{"issue":"1","key":"9288_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12883-024-03667-3","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wu J, Lin J et al (2024) Characteristics of recurrence in area postrema\u2013onset NMO spectrum disorder. BMC Neurol 24(1):165","journal-title":"BMC Neurol"},{"key":"9288_CR13","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","volume":"136","author":"L Matthews","year":"2013","unstructured":"Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of multiple sclerosis and neuromyelitis optica spectrum disorder lesions on MRI. Brain 136:1799\u20131815","journal-title":"Brain"},{"issue":"17","key":"9288_CR14","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","volume":"91","author":"E Shosha","year":"2018","unstructured":"Shosha E, Bennett JL, Cree BAC et al (2018) Frequency and diagnostic performance of area postrema syndrome in AQP4-IgG positive NMOSD. Neurology 91(17):e1642\u2013e1651","journal-title":"Neurology"},{"key":"9288_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12883-025-04215-3","volume":"25","author":"H Yin","year":"2025","unstructured":"Yin H, Wang Y, Xu Y (2025) Neuromyelitis optica spectrum disorders with recurrent syncope due to area postrema syndrome: a case report and literature review. BMC Neurol 25:339","journal-title":"BMC Neurol"},{"key":"9288_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"9288_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"CF Lucchinetti","year":"2000","unstructured":"Lucchinetti CF, Br\u00fcck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for pathogenesis. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"9288_CR18","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","volume":"133","author":"J Palace","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon beta treatment in neuromyelitis optica: increase in relapses and disability. Brain 133:2578\u20132597","journal-title":"Brain"},{"key":"9288_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81774","author":"K Asahi","year":"2025","unstructured":"Asahi K (2025) A case of refractory hiccups and numbness as the initial presentation of multiple sclerosis. Cureus. https:\/\/doi.org\/10.7759\/cureus.81774","journal-title":"Cureus"},{"key":"9288_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibody-associated disease. Nat Rev Neurol 15:89\u2013102","journal-title":"Nat Rev Neurol"},{"key":"9288_CR21","doi-asserted-by":"publisher","first-page":"e30633","DOI":"10.1016\/j.heliyon.2024.e30633","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhangbao J, Xu J, Shi Q, Wang Y, Li Y (2024) The distinction of area postrema syndrome between MOGAD and NMOSD. Heliyon 10:e30633","journal-title":"Heliyon"},{"issue":"12","key":"9288_CR22","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"C Jury\u0144czyk","year":"2017","unstructured":"Jury\u0144czyk C, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140(12):3128\u20133138","journal-title":"Brain"},{"issue":"3","key":"9288_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","volume":"76","author":"D Dubey","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL et al (2019) Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol 76(3):301\u2013309","journal-title":"JAMA Neurol"},{"issue":"13","key":"9288_CR24","first-page":"1343","volume":"87","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP et al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy. Neurology 87(13):1343\u20131349","journal-title":"Neurology"},{"key":"9288_CR25","doi-asserted-by":"crossref","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ et al Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. JAMA Neurol 73(11):1297\u20131307","DOI":"10.1001\/jamaneurol.2016.2549"},{"key":"9288_CR26","doi-asserted-by":"publisher","first-page":"1538602","DOI":"10.3389\/fneur.2025.1538602","volume":"16","author":"Q Li","year":"2025","unstructured":"Li Q, Teng J, Zhang X et al (2025) Area postrema syndrome in autoimmune GFAP astrocytopathy: clinical and imaging features. Front Neurol 16:1538602","journal-title":"Front Neurol"},{"issue":"1","key":"9288_CR27","doi-asserted-by":"publisher","first-page":"e40614","DOI":"10.1016\/j.heliyon.2024.e40614","volume":"11","author":"JR Mu\u00f1oz-Z\u00fa\u00f1iga","year":"2024","unstructured":"Mu\u00f1oz-Z\u00fa\u00f1iga JR, Calles JR, V\u00e1zquez M et al (2024) Area postrema syndrome in systemic lupus erythematosus: a case series and review of the literature. Heliyon 11(1):e40614","journal-title":"Heliyon"},{"key":"9288_CR28","first-page":"2095","volume":"52","author":"JS Kim","year":"1999","unstructured":"Kim JS (1999) Hiccups in lateral medullary infarction. Neurology 52:2095\u20132097","journal-title":"Neurology"},{"key":"9288_CR29","doi-asserted-by":"publisher","first-page":"e01439","DOI":"10.1002\/brb3.1439","volume":"9","author":"R Itabashi","year":"2019","unstructured":"Itabashi R, Endo K, Saito T et al (2019) Supratentorial infarcts accompanying hiccup. Brain Behav 9:e01439","journal-title":"Brain Behav"},{"key":"9288_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247830","volume":"15","author":"T Shankar","year":"2022","unstructured":"Shankar T, Pillai A, Kaeley N et al (2022) Intractable hiccups as the harbinger of a diffuse pontine glioma. BMJ Case Rep 15:e247830","journal-title":"BMJ Case Rep"},{"key":"9288_CR31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.clineuro.2012.01.017","volume":"114","author":"JH Kang","year":"2012","unstructured":"Kang JH, Lee JH, Kim MJ et al (2012) Central nervous system infections presenting with persistent hiccups. Clin Neurol Neurosurg 114:1010\u20131013","journal-title":"Clin Neurol Neurosurg"},{"key":"9288_CR32","first-page":"1105","volume":"53","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Neurology 53:1105\u20131107","journal-title":"Neurology"},{"key":"9288_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMoa1900866","volume":"381","author":"SJ Pittock","year":"2019","unstructured":"Pittock SJ, Berthele A, Fujihara K et al (2019) Eculizumab in aquaporin-4\u2013positive neuromyelitis optica spectrum disorder. N Engl J Med 381:614\u2013625","journal-title":"N Engl J Med"},{"key":"9288_CR34","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","volume":"381","author":"T Yamamura","year":"2019","unstructured":"Yamamura T, Kleiter I, Fujihara K et al (2019) Trial of satralizumab in neuromyelitis optica spectrum disorder. N Engl J Med 381:2114\u20132124","journal-title":"N Engl J Med"},{"key":"9288_CR35","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","volume":"394","author":"BAC Cree","year":"2019","unstructured":"Cree BAC, Bennett JL, Kim HJ et al (2019) Inebilizumab for the treatment of neuromyelitis optica spectrum disorder. Lancet 394:1352\u20131363","journal-title":"Lancet"},{"key":"9288_CR36","first-page":"1186","volume":"52","author":"EN Moretto","year":"1999","unstructured":"Moretto EN, Wee B, Wiffen PJ, Murchison AG, Harrison JD (1999) Gabapentin in the treatment of persistent hiccups. Neurology 52:1186\u20131187","journal-title":"Neurology"},{"key":"9288_CR37","doi-asserted-by":"crossref","first-page":"e7108","DOI":"10.1097\/MD.0000000000007108","volume":"96","author":"JE Kim","year":"2017","unstructured":"Kim JE, Lee MK, Lee DK, Kim YH, Lee SM, Lim SH (2017) Continuous cervical epidural block for intractable hiccups. Med (Baltim) 96:e7108","journal-title":"Med (Baltim)"},{"issue":"8","key":"9288_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/1352458511431728","volume":"18","author":"S Jarius","year":"2012","unstructured":"Jarius S, Paul F, Franciotta F et al (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Multiple Scler J 18(8):1135\u20131143","journal-title":"Multiple Scler J"},{"issue":"1","key":"9288_CR39","first-page":"32","volume":"90","author":"T Kalincik","year":"2021","unstructured":"Kalincik T et al (2021) Early predictors and outcome measures in neuromyelitis optica spectrum disorder cohorts. Ann Neurol 90(1):32\u201344","journal-title":"Ann Neurol"},{"issue":"2","key":"9288_CR40","first-page":"150","volume":"19","author":"SR Hinson","year":"2020","unstructured":"Hinson SR, Romero MF, Popescu BFG et al (2020) Astrocyte injury biomarkers in neuromyelitis optica spectrum disorder. Lancet Neurol 19(2):150\u2013160","journal-title":"Lancet Neurol"},{"key":"9288_CR41","first-page":"577755","volume":"376","author":"ML Yang","year":"2023","unstructured":"Yang ML, Lei S et al (2023) Serum glial fibrillary acidic protein as a biomarker of disease activity in neuromyelitis optica spectrum disorder. J Neuroimmunol 376:577755","journal-title":"J Neuroimmunol"},{"key":"9288_CR42","doi-asserted-by":"publisher","first-page":"175628642513457","DOI":"10.1177\/17562864251345792","volume":"18","author":"P Schindler","year":"2025","unstructured":"Schindler P, Taieb G, Uzawa A et al (2025) Association of serum GFAP and neurofilament light chain with MRI volumes in AQP4-IgG+ NMOSD and MOGAD patients. Ther Adv Neurol Disord 18:17562864251345792","journal-title":"Ther Adv Neurol Disord"},{"key":"9288_CR43","unstructured":"Adhikari Y, Huda S, Aoki M et al (2025) Serum glial fibrillary acidic protein and neurofilament light chain: current evidence and implications in NMOSD. Neurology 105(9)"},{"issue":"2","key":"9288_CR44","first-page":"373","volume":"27","author":"E Sbardella","year":"2017","unstructured":"Sbardella E, Tona F et al (2017) Advanced MRI techniques in demyelinating brainstem disorders. Neuroimaging Clin N Am 27(2):373\u2013389","journal-title":"Neuroimaging Clin N Am"},{"issue":"10","key":"9288_CR45","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/1352458519860319","volume":"26","author":"PS Morgan","year":"2020","unstructured":"Morgan PS, Altmann DR et al (2020) High-resolution brainstem MRI in inflammatory central nervous system disease. Mult Scler 26(10):1247\u20131258","journal-title":"Mult Scler"},{"issue":"9","key":"9288_CR46","first-page":"807","volume":"17","author":"CJ Mathias","year":"2018","unstructured":"Mathias CJ, Low DA, Iodice V et al (2018) Autonomic dysfunction in neurological disease: clinical features and pathophysiology. Lancet Neurol 17(9):807\u2013820","journal-title":"Lancet Neurol"},{"issue":"2","key":"9288_CR47","first-page":"265","volume":"31","author":"P Flachenecker","year":"2021","unstructured":"Flachenecker P, Rieckmann P et al (2021) Cardiovascular autonomic involvement in neuromyelitis optica spectrum disorders. Clin Auton Res 31(2):265\u2013273","journal-title":"Clin Auton Res"},{"issue":"5","key":"9288_CR48","first-page":"2526","volume":"270","author":"K Lehmann-Horn","year":"2023","unstructured":"Lehmann-Horn K, Wrzos C et al (2023) Early treatment strategies in acute neuromyelitis optica spectrum disorder attacks. J Neurol 270(5):2526\u20132538","journal-title":"J Neurol"},{"key":"9288_CR49","first-page":"1004120","volume":"15","author":"JB Havla","year":"2024","unstructured":"Havla JB, Koschel J et al (2024) Complement inhibition and acute immunotherapy in neuromyelitis optica spectrum disorder. Front Immunol 15:1004120","journal-title":"Front Immunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09288-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:34:22Z","timestamp":1791848062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9288"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09288-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a narrative review based on previously published studies and publicly available data. No new human participants, patient data, or animal experiments were involved in the preparation of this manuscript. Therefore, ethical approval from an institutional review board was not required. All cited studies were conducted in accordance with relevant ethical standards and institutional guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest related to this work.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"712"}}